Healthcare Services

One of the Major Drivers of the Autoimmune Disease Diagnosis Market Is the Elevated Incidence Of Autoimmune Diseases A Catalyst For The Autoimmune Disease Diagnosis Market

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Autoimmune Disease Diagnosis Market By The End Of 2030?

The autoimmune disease diagnosis market has shown robust expansion in recent years. This market is anticipated to increase from $6.2 billion in 2025 to $6.74 billion in 2026, registering a compound annual growth rate (CAGR) of 8.8%. The growth observed in previous periods is attributable to factors such as the rising incidence of autoimmune diseases, better access to immunoassay technologies, the broadening of clinical laboratory networks, heightened physician awareness of autoimmune conditions, and the widespread adoption of routine screening tests.

The autoimmune disease diagnosis market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $9.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the forecast period include a heightened need for prompt and precise diagnosis, the increasing application of AI-assisted diagnostic analytics, the development of tailored diagnostic methods, expanding investments in autoimmune research, and greater integration of point-of-care testing. Key trends expected during this period involve the wider adoption of sophisticated immunological testing, increased utilization of autoantibody panels, enhanced integration of multiplex diagnostic platforms, the expansion of laboratory automation, and a greater emphasis on detecting diseases at an early stage.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Autoimmune Disease Diagnosis Market?

The high occurrence of autoimmune diseases has fueled the expansion of the autoimmune disease diagnosis market. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own healthy cells, tissues, or organs. The rise in autoimmune diseases is linked to increased exposure to environmental triggers such as pollution and infections, as well as lifestyle changes that can disrupt immune regulation. Accurate diagnosis of these diseases is essential for identifying the specific immune disorder, allowing for appropriate treatment to commence and better management of disease progression. For example, in March 2023, the Society for Women’s Health Research, a U.S-based non-profit organisation, reported that autoimmune diseases are estimated to affect 23.5 million to 50 million individuals. Furthermore, the global rates of autoimmune diseases are observed to be increasing by 3-9 percent each year. Therefore, the growing incidence of autoimmune diseases worldwide is a key factor driving the autoimmune disease diagnosis market.

Which Segment Classifications Shape The Autoimmune Disease Diagnosis Market?

The autoimmune disease diagnosis market covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments

2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

3) By End User: Clinical Laboratories, Hospitals, Other End Users

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes

What Trends Are Affecting The Expansion Of The Autoimmune Disease Diagnosis Market?

Leading companies in the autoimmune disease diagnosis market are concentrating on technological breakthroughs, particularly multiplex autoantibody assay platforms. These platforms aim for thorough, early, and accurate identification of autoimmune conditions, thereby enhancing diagnostic precision and patient care. A multiplex autoantibody assay platform facilitates the concurrent detection of numerous disease-specific autoantibodies from a single patient sample. This approach elevates sensitivity and specificity beyond conventional single-analyte ELISA or immunofluorescence methods, concurrently decreasing the required sample volume and processing duration. As an illustration, in January 2025, Exagen Inc., a U.S.-based diagnostics firm, introduced its AVISE CTD platform, which incorporates novel biomarker assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This platform identifies new biomarkers like TIgG, TIgM, and TC4d, allowing medical professionals to more precisely differentiate between overlapping autoimmune conditions and simplify patient diagnosis, all while integrating smoothly with existing testing procedures.

Which Companies Are Expanding Their Footprint In The Autoimmune Disease Diagnosis Market?

Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics

Read the full autoimmune disease diagnosis market report here:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Which Regions Are Projected To Dominate The Autoimmune Disease Diagnosis Market In The Coming Years?

North America was the largest region in the autoimmune disease diagnosis market in 2025. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Disease Diagnosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp

Browse Through More Reports Similar to the Global Autoimmune Disease Diagnosis Market 2026, By The Business Research Company

Autoimmune Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Immunodiagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795